Taurine Chloramine and Its Effects on Matrix Metalloproteinases in Rheumatoid Arthritis
Author Information
Author(s): Kim Kyoung Soo, Park Eun Kyung, Ju Seung Min, Jung Hye-Sook, Bang Jun Soo, Kim Chaekyun, Lee Yeon-Ah, Hong Seung-Jae, Lee Sang-Hoon, Yang Hyung-In, Yoo Myung Chul
Primary Institution: East-West Bone & Joint Research Center, East-West Neo Medical Center, Kyung Hee University
Hypothesis
Taurine chloramine (TauCl) plays a role in downregulating the expression of matrix metalloproteinases (MMPs) in interleukin-1β stimulated fibroblast-like synoviocytes.
Conclusion
Taurine chloramine differentially inhibits the expression of MMP-1 and MMP-13 in rheumatoid arthritis fibroblast-like synoviocytes.
Supporting Evidence
- IL-1β increased the expression of MMP-1 and MMP-13 in rheumatoid arthritis fibroblast-like synoviocytes.
- Taurine chloramine significantly inhibited the expression of MMP-13 at concentrations of 400 to 600 μmol/l.
- At 800 μmol/l, taurine chloramine inhibited both MMP-1 and MMP-13 expression.
Takeaway
Taurine chloramine helps reduce certain proteins that can damage joints in people with arthritis.
Methodology
The study used real-time PCR, ELISA, and Western blot analyses to assess the effects of TauCl on MMP expression in fibroblast-like synoviocytes stimulated with IL-1β.
Potential Biases
Potential bias in patient selection and variability in fibroblast-like synoviocyte responses.
Limitations
The study's findings may not be generalizable to all patients with rheumatoid arthritis due to variability in individual responses to TauCl.
Participant Demographics
Patients with rheumatoid arthritis undergoing therapeutic joint surgery.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website